Adaptation of antibiotic treatment to clinical practice guidelines in patients aged ≥65 years hospitalised due to community-acquired pneumonia

被引:3
作者
Fernandez-Sierra, M. A. [1 ]
Rueda-Domingo, M. T. [1 ]
Rodriguez-del-Aguila, M. M. [1 ]
Perez-Lozano, M. J. [2 ]
Force, L. [3 ]
Fernandez-Villa, T. [4 ]
Astray, J. [5 ]
Egurrola, M. [6 ]
Castilla, J. [7 ,8 ]
Sanz, F. [9 ]
Toledo, D. [8 ,10 ]
Dominguez, A. [8 ,10 ]
机构
[1] Hosp Univ Virgen de las Nieves, UGC Prevent Promoc & Vigilancia SaLud, Granada, Spain
[2] Hosp VaLme, UGC Prevent Promoc & Vigiiancia SaLud, Seville, Spain
[3] Hosp Mataro, Barcelona, Spain
[4] Univ Leon, Inst Biomed IBIOMED, GIIGAS, Leon, Spain
[5] Consejeria Sanidad Madrid, Madrid, Spain
[6] Hosp GaLdakao, UsansoLo, Vizcaya, Spain
[7] IdiSNA, Inst Salud Publ Navarra, Pamplona, Spain
[8] CIBERESP, Madrid, Spain
[9] Consorci Hosp Gen Univ Valencia, Valencia, Spain
[10] Univ Barcelona, Dept Med, Barcelona, Spain
关键词
Antibiotic treatment; community-acquired pneumonia; correctness; elderly; hospital; MANAGEMENT; ADULTS; IMMUNIZATION; ADHERENCE; DISEASES; THERAPY; SOCIETY; IMPACT;
D O I
10.1017/S0950268818002121
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Early, conforming antibiotic treatment in elderly patients hospitalised for community-acquired pneumonia (CAP) is a key factor in the prognosis and mortality. The objective was to examine whether empirical antibiotic treatment was conforming according to the Spanish Society of Pulmonology and Thoracic Surgery guidelines in these patients. Multicentre study in patients aged >= 65 years hospitalised due to CAP in the 2013-14 and 2014-15 influenza seasons. We collected socio-demographic information, comorbidities, influenza/pneumococcal vaccination history and antibiotics administered using a questionnaire and medical records. Bivariate analyses and multilevel logistic regression were made. In total, 1857 hospitalised patients were included, 82 of whom required intensive care unit (ICU) admission. Treatment was conforming in 51.4% (95% confidence interval (CI) 49.1-53.8%) of patients without ICU admission and was associated with absence of renal failure without haemodialysis (odds ratio (OR) 1.49, 95% CI 1.15-1.95) and no cognitive dysfunction (OR 1.71, 95% CI 1.25-2.35), when the effect of the autonomous community was controlled for. In patients with ICU admission, treatment was conforming in 45.1% (95% CI 34.1-56.1%) of patients and was associated with the hospital visits in the last year (<3 vs. >= 3, OR 2.70, 95% CI 1.03-7.12) and there was some evidence that this was associated with season. Although the reference guidelines are national, wide variability between autonomous communities was found. In patients hospitalised due to CAP, health services should guarantee the administration of antibiotics in a consensual manner that is conforming according to clinical practice guidelines.
引用
收藏
页码:1870 / 1877
页数:8
相关论文
共 50 条
  • [21] Duration of Antibiotic Treatment in Community-Acquired Pneumonia
    Uranga Echeverria, Ane
    ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (12): : 613 - 614
  • [22] Antibiotic Treatment of Children With Community-Acquired Pneumonia: Comparison of Penicillin or Ampicillin Versus Cefuroxime
    Dinur-Schejter, Yael
    Cohen-Cymberknoh, Malena
    Tenenbaum, Ariel
    Brooks, Rebecca
    Averbuch, Diana
    Kharasch, Sigmund
    Kerem, Eitan
    PEDIATRIC PULMONOLOGY, 2013, 48 (01) : 52 - 58
  • [23] Treatment of community-acquired pneumonia - IDSA guidelines
    Bernstein, JM
    CHEST, 1999, 115 (03) : 9S - 13S
  • [24] Radiological resolution of community-acquired pneumonia in hospitalised patients in North India
    Pandit, Sayar Ahmad
    Koul, Hazique P.
    Saif, Saniya
    LUNG INDIA, 2025, 42 (02) : 134 - 139
  • [25] Community-Acquired Pneumonia A Review of Current Practice Guidelines
    Anderson, Emily M.
    Spencer, Dustin D.
    Walroth, Todd A.
    ADVANCED EMERGENCY NURSING JOURNAL, 2008, 30 (03) : 209 - 217
  • [26] Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England
    Campling, James
    Jones, Dylan
    Chalmers, James
    Jiang, Qin
    Vyse, Andrew
    Madhava, Harish
    Ellsbury, Gillian
    Rabe, Adrian
    Slack, Mary
    BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
  • [27] C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia
    Thiem, Ulrich
    Niklaus, David
    Sehlhoff, Bettina
    Stueckle, Christoph
    Heppner, Hans Juergen
    Endres, Heinz Gerd
    Pientka, Ludger
    AGE AND AGEING, 2009, 38 (06) : 693 - 697
  • [28] Community-acquired pneumonia:: usefulness of clinical presentation in the selection of antibiotic treatment
    Ruiz, A
    Falguera, M
    Sacristán, O
    Vallverdú, M
    Cabré, X
    Pérez, J
    Ferrer, G
    MEDICINA CLINICA, 2002, 119 (17): : 641 - 643
  • [29] COMMUNITY-ACQUIRED PNEUMONIA: COMPARISON OF ETIOLOGICAL DIAGNOSTIC METHODS IN CLINICAL PRACTICE
    Pustovalov, A. A.
    Rvacheva, A. V.
    Chuchalin, A. G.
    Sokolov, E. I.
    Khaptkhaeva, G. E.
    Tkachev, G. A.
    Zykov, K. A.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (04) : 11 - 16
  • [30] Antibiotic treatment of community-acquired and hospital-acquired pneumonia
    Simon, Susanne
    Rademacher, Jessica
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2023, 118 (06) : 454 - 463